Sufentanil Citrate Market By Applications 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Sufentanil Citrate Market
Sufentanil Citrate Market: By Applications (Surgery, Epidural Anaesthesia and Medicinal Application) & By Geography (North America, Europe, Asia Pacific & Rest of the World (RoW))-Forecast (2016-2021)
Report Code : HCR 0387
Updated Date: 07 September, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Sufentanil, also known as R30730 or brand name Sufenta, is a synthetic opioid analgesic drug which is considerably more potent than its parent drug, fentanyl, morphine. It is used for producing anesthesia for surgery. It may also be used with other medicines as part of epidural anesthesia during labor and delivery to decrease pain. Globally, development of efficient and advanced technology and increase in number of medical surgeries and gynaecological surgeries are the prime growth drivers of Sufentanil Citrate market. Apart from this, augmentation in cardiovascular diseases and associated surgeries, and emerging economies are expected to be the key growth drivers during the period of study.

 Sufentanil Citrate Market

Geographically North America dominates the sufentanil citrate market driven by best in class infrastructure, easy access to healthcare, higher awareness amongst physicians about the advanced technological treatment, higher spending on R&D by large pharmaceutical players in the region and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for sufentanil citrate market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China and India in this region.

This report identifies the global Sufentanil Citrate market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Sufentanil Citrate market.

This report segments Sufentanil Citrate market on the basis of type, procedures, and regional market as follows:
  • This report on Sufentanil Citrate Market is segmented on the basis of major applications of sulfentanil citrate. Some of the major applications of sulfantanil citrate covered in this report as follows: Surgery, Epidural Anaesthesia and Medicinal Application and for nutraceuticals
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Sufentanil Citrate market. Some of the major companies’ profiles in detail are as follows:
  • Wuhan Fengzhulin
  • Spectrum
  • Macfarlan Smith
  • Mallinckrodt Pharmaceuticals
  • Akorn, Inc
1. Sufentanil Citrate Market – Overview
2. Executive Summary 
3. Sufentanil Citrate Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Sufentanil Citrate Market– Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Increase in number of medical surgeries/Increase in gynaecological surgeries
   4.2. Restraints
      4.2.1. Higher cost of interventional devices 
   4.3. Opportunities
      4.3.1. Augmentation in cardiovascular diseases and associated surgeries
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Sufentanil Citrate Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Sufentanil Citrate Market, By Applications
   6.1. Surgery
   6.2. Epidural Anaesthesia
   6.3. Medicinal Application
   6.4. Others
7. Sufentanil Citrate Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Sufentanil Citrate – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Akorn, Inc
   9.2. Mallinckrodt Pharmaceuticals
   9.3. Wuhan Fengzhulin
   9.4. Spectrum
   9.5. Macfarlan Smith
   9.6. EuroCept
   9.7. IDT Biologika
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports